Document:

<PAGE>
                                                                    EXHIBIT 10.8

DATED                                                               May 18, 2005

                           ICURIE LAB HOLDINGS LIMITED

                                       and

                           CHL INVESTMENT PARTNERSHIP

                                       and

                           HANSEN GRAY & COMPANY, INC

                             REVENUE SHARE AGREEMENT

                                 TAYLOR WESSING
                                    Carmelite
                             50 Victoria Embankment
                                   Blackfriars
                                 London EC4Y 0DX

                             Tel +44 (0)20 7300 7000
                             Fax +44 (0)20 7300 7100
                                  DX 41 London

                                  Ref: SXW/MXR

<PAGE>

                                      INDEX

<TABLE>
<CAPTION>
CLAUSE NO.                                                                                          PAGE NO.
<C>                                                                                                 <C>
1.    DEFINITIONS AND INTERPRETATION................................................................   1
2.    PROVISION OF FINANCIAL INFORMATION............................................................   3
3.    REVENUE SHARE.................................................................................   3
4.    TERMINATION...................................................................................   3
5.    NOTICES AND OTHER COMMUNICATIONS..............................................................   3
6.    ASSIGNMENT....................................................................................   5
7.    NO SET-OFF....................................................................................   5
8.    ENTIRE AGREEMENT..............................................................................   5
9.    GENERAL.......................................................................................   6
10.   GOVERNING LAW AND JURISDICTION................................................................   6

</TABLE>

<PAGE>

THIS AGREEMENT is made on  May 18, 2005

BETWEEN

(1)   ICURIE LAB HOLDINGS LIMITED (registered in England and Wales under number
      05075133) the registered office of which is at 12 Plumtree Court, London
      EC4A 4HT (the "COMPANY");

(2)   CHL INVESTMENT PARTNERSHIP the principal place of business of which is at
      475-1 Gwachundong, Gwachun Shi, Gyeong Gi Do, Korea, 427-080 ("CHL"); and

(3)   HANSEN GRAY & COMPANY, INC. the principal place of business which is at
      3875 Johns Creek Parkway, Suite A, Suwanee, Georgia, 30024, United States
      ("HG").

INTRODUCTION

(A)   Since the Company's incorporation on 16 March 2004 and subsequent
      investment by HG on 16 March 2004, HG and CHL have worked to expand the
      Company's business and develop certain cooling technology.

(B)   On May 18, 2005, the shareholders of the Company unanimously agreed that
      each of CHL and HG should have the right to receive certain payments in
      accordance with the terms and conditions set out in this agreement.

AGREED TERMS

1.    DEFINITIONS AND INTERPRETATION

1.1   Definitions

      In this agreement including the introduction, capitalised terms used, have
      the meaning set out below:

      "ACCOUNTS" means the audited accounts of the Company for a Financial
      Period;

      "BUSINESS" means the business of the Company as carried on at today's
      date;

      "BUSINESS DAY" means a day other than a day that is a Saturday, Sunday or
      public holiday in England;

      "COMPANIES ACT" means the Companies Act 1985;

      "COMMENCEMENT DATE" means today's date;

      "CUMULATIVE REVENUE" means the aggregate of all revenue received by the
      Company after the date of this agreement in respect of the Business;

<PAGE>

      "FINANCIAL PERIOD" - means an accounting period as defined in the
      Companies Act;

      "FIRST QUALIFYING PERIOD" means the first Financial Period ending after
      the date of this agreement in which the Cumulative Revenue of Company is
      at least equal to the Qualifying Revenue Amount;

      "PAYMENTS" means any payments made to HG and CHL in accordance with the
      terms of this agreement;

      "QUALIFYING PERIODS" means the First Qualifying Period and/or any
      Subsequent Qualifying Periods;

      "QUALIFYING REVENUE AMOUNT" means US$25,000,000 (twenty five million US
      dollars);

      "SUBSEQUENT QUALIFYING PERIOD" means any Financial Period following the
      First Qualifying Period;

      "TAX" or "TAXATION" means any form of tax (including, but not limited to,
      income tax required to be deducted or withheld or accounted for in respect
      of any payment), levy, impost, duty, charge, contribution (including, but
      not limited to, National Insurance contributions), deduction or
      withholding whenever imposed, collected or assessed by, or payable to, a
      Tax Authority and any penalty, charge, cost and interest included in or
      relating to any of the above or to any obligation in respect of any of the
      above;

      "TAX AUTHORITY" means any government, state or municipality or any local,
      state, federal or other fiscal, revenue, customs or excise authority, body
      or official in the United Kingdom or elsewhere; and.

      "TAXATION LIABILITY" " means the liability of the Company to make payments
      of, or in respect of, Tax.

1.2   Interpretation

      In this agreement:

      (a)   reference to:

            (i)   any statute or statutory provision includes a reference:

                  (A)   to that statute or statutory provision as from time to
                        time consolidated, modified, re-enacted (with or without
                        modification) or replaced by any statute or statutory
                        provision; and

                  (B)   any subordinate legislation made under the relevant
                        statutory provision;

            (ii)  the singular includes the plural and vice versa and any gender
                  includes other genders;

                                       2

<PAGE>

            (iii) "THIS AGREEMENT" includes this agreement as amended or
                  supplemented from time to time;

      (b)   the table of contents and the headings to clauses and schedules are
            to be ignored in construing this agreement;

      (c)   the words, "PARENT UNDERTAKING", "SUBSIDIARY UNDERTAKING" and
            "UNDERTAKING" have the meanings given to them in sections 258 and
            259 of the Companies Act 1985.

2.    PROVISION OF FINANCIAL INFORMATION

2.1   Within 25 Business Days of the approval of the Accounts by the Company in
      general meeting the Company shall procure that a copy of the Accounts is
      sent to each of CHL and HG.

3.    REVENUE SHARE

3.1   When the Company achieves Cumulative Revenue equal to the Qualifying
      Revenue Amount, HG and CHL shall receive the following amounts payable in
      accordance with clause 3.2;

      (a)   in the First Qualifying Period:

            (i)   in respect of CHL, 1.14% of the Cumulative Revenue minus
                  $25,000,000 USD;

            (ii)  in respect of HG, 0.86% of the Cumulative Revenue minus
                  $25,000,000 USD;

      (b)   in any Subsequent Qualifying Period:

            (i)   in respect of CHL, 1.14% of (1) the Cumulative Revenue minus
                  $25,000,000 USD, less (2) the aggregate of Payments made in
                  respect of previous Qualifying Periods;

            (ii)  in respect of HG, 0.86% of (1) the Cumulative Revenue minus
                  $25,000,000 USD, less (2) the aggregate of Payments made in
                  previous Qualifying Periods.

3.2   Any amounts payable to CHL and HG pursuant to clause 3.1 shall be made
      within 25 Business Days of the adoption of the Accounts for the relevant
      Qualifying Period by bank transfer to such bank account as CHL and HG may
      notify to the Company in writing from time to time.

4.    TERMINATION

4.1   This agreement shall terminate when the Payments received by HG and CHL
      under this agreement equal in aggregate US$50,000,000 (fifty million US
      dollars).

5.    NOTICES AND OTHER COMMUNICATIONS

5.1   Where this agreement provides for the giving of notice or the making of
      any other communication, such notice or communication shall not (unless
      otherwise expressly provided) be effective unless given or made in writing
      in English in accordance with the following provisions of this clause 5.

                                       3

<PAGE>

5.2   Any notice or communication to be given or made under or in connection
      with this agreement may be:

      (a)   delivered or sent by post to:

            the Company               The address set out at the front of this
                                      agreement.

            CHL                       The address set out at the front of this
                                      agreement.

            HG                        The address set out at the front of this
                                      agreement.

            or

      (b)   sent by fax, email or other electronic communication, to:

            the Company               To be provided by the Company at a later
                                      date

            CHL                       822-245-23650

            HG                        (678) 542-2100

            and shall be marked in the case of the Company for the attention of
            the Managing Director in the case of HG, for the attention of Alan
            Miller and in the case of CHL for the attention of Dr. Lee.

5.3   Any notice or other communication so delivered or sent shall (subject to
      the provisions of clause 5.4 (c)) be deemed to have been served at the
      time when it is received at the address to which it is delivered or sent
      except that if that time is between 5.30 p.m. on a Relevant Day and 9.00
      a.m. on the next Relevant Day it shall be deemed to have been served at
      9.00 a.m. on the second of such Relevant Days.

5.4   Where a party has given notice to the others of any different address or
      number to be used for the purposes of this clause then such different
      address or number shall be substituted for that shown above.

      For the purposes of this clause:

      (a)   "POSTAL ADDRESS" means the address shown in clause 5.2(a).

      (b)   "RELEVANT DAY" means any day other than a Saturday, Sunday or a day
            which is a public holiday at the Postal Address of the receiving
            party;

      (c)   any reference to a time is to the time at the Postal Address of the
            receiving party;

                                       4

<PAGE>

      (d)   reference to an electronic communication (including a fax) being
            received shall, in the case of a party which is a corporate body or
            partnership, mean receipt at the first device hosting electronic
            communication services for that corporate body or partnership at
            which it is received and, in the case of a party who is an
            individual, shall mean receipt on a device owned (or used for
            reading electronic communications) by the individual which receipt
            shall, notwithstanding the provisions of clause 5.3, and in the
            absence of evidence of earlier receipt, be deemed to have occurred
            96 hours after sending; and

      (e)   "electronic communication" has the same meaning as in the Electronic
            Communications Act 2000.

6.    ASSIGNMENT

6.1   CHL and HG may at any time assign or transfer its rights under this
      agreement to any party provided that such an assignment or transfer does
      not increase the Company's obligations in any way.

7.    WITHHOLDING

7.1   The Company shall be entitled to withhold and/or deduct any amounts from
      any payment due under this agreement in respect of Tax as are necessary to
      satisfy any Taxation Liability which is incurred by the Company in
      relation to making the Payments to HG and CHL .

8.    ENTIRE AGREEMENT

8.1   This agreement constitutes the entire agreement between the parties about
      the subject matter of this agreement and supersedes all earlier
      understandings and agreements between any of the parties and all earlier
      representations by any party about such subject matter).

8.2   The parties have not entered into this agreement in reliance upon any
      representation, warranty or promise and no such representation or warranty
      or any other term is to be implied in it whether by virtue of any usage or
      course of dealing or otherwise except as expressly set out in it.

8.3   If a party has given any representation, warranty or promise then, (except
      to the extent that it has been set out in this agreement) the party to
      whom it is given waives any rights or remedies which it may have in
      respect of it.

8.4   This clause shall not exclude the liability of a party for fraud or
      fraudulent misrepresentation or concealment or any resulting right to
      rescind this agreement.

                                       5

<PAGE>

9.    GENERAL

      The Contracts (Rights of Third Parties) Act 1999

9.1   Except as provided in clause 6.1 and 9.2, a person who is not a party has
      no right to enforce any term of this agreement under the Contracts (Rights
      of Third Parties) Act 1999.

9.2   Dr. Lee may enforce the terms of this agreement on behalf of CHL
      Partnership notwithstanding that he is not a party.

      No Partnership

9.3   This agreement is not intended to and does not operate to create a
      partnership between the parties or any of them, or to authorise any party
      to act as agent for any other, and no party shall have authority to act in
      the name or on behalf of or otherwise to bind any other party.

      Variation

9.4   This agreement may only be varied in writing signed by or on behalf of
      each of the parties.

      Waiver and Remedies

9.5   A waiver of any term, provision or condition of, and any consent or
      approval granted under, this agreement will be valid only if it is in
      writing, signed by the party giving the waiver or granting the consent or
      approval. Any such waiver, consent or approval will be valid only in the
      particular instance and for the particular purpose for which it is given
      and will not constitute a waiver of any other right or remedy.

9.6   Any failure (in whole or in part) to exercise or delay in exercising any
      right, power or remedy ("RIGHT") available under this agreement or in law
      will not constitute a waiver of that or any other Right nor will any
      single or partial exercise of any Right preclude any other or further
      exercise of that or any other Right. The rights and remedies provided by
      this agreement are cumulative and (unless otherwise expressly stated in
      this agreement) and may be exercised without excluding any other rights or
      remedies available in law.

      Counterparts

9.7   This agreement may be executed in any number of counterparts, each of
      which, when executed and delivered, is an original, but all the
      counterparts taken together shall constitute one document. This agreement
      shall not take effect until all the parties have executed it.

10.   GOVERNING LAW AND JURISDICTION

10.1  This agreement (and any dispute or claim relating to it, its
      enforceability or its termination) is to be governed by and construed in
      accordance with English law.

10.2  The courts of England and Wales shall have exclusive jurisdiction to
      settle any dispute between the parties whether arising in connection with
      this agreement or otherwise. The parties to this agreement irrevocably
      submit to such jurisdiction and waive any objection to it, on the ground
      of inconvenient forum or otherwise. No party shall oppose the recognition
      or

                                       6
<PAGE>

      enforcement of a judgment, order or decision of those courts in respect of
      any such claim or dispute by the courts of any state which, under the laws
      and rules applicable in that state, are competent or able to grant such
      recognition or enforcement.

10.3  A party may bring proceedings in the courts of any state other than
      England and Wales for the purpose of seeking:

      (a)   an injunction, order or other non-monetary relief (or its equivalent
            in such other state); and/or

      (b)   any relief or remedy which, if it (or its equivalent) were granted
            by the courts of England and Wales, would not be enforceable in such
            other state.

This deed has been executed and delivered as a deed on the date shown at the
beginning.

                                       7
<PAGE>

SIGNED AS A DEED                        )
for and on behalf of                    )
ICURIE LAB HOLDINGS LIMITED             )
                                                Director, Jeong Hyun  Lee

                                                /s/ Jeong Hyun Lee
                                                ---------------------------
                                                Director, Alan B. Miller

                                                /s/ Alan Miller
                                                ---------------------------

SIGNED AS A DEED                         )
for and on behalf of                     )
HANSEN GRAY & COMPANY, INC.              )
                                                Authorised signatory,
                                                David M. Walker, President

                                                /s/ David Walker
                                                ---------------------------

                                                Authorized signatory,
                                                Alan B. Miller, Director

                                                /s/ Alan Miller
                                                ---------------------------

SIGNED AS A DEED                         )
for and on behalf of                     )
CHL INVESTMENT PARTNERSHIP.              )

                                                Authorised signatory,
                                                Jeong Hyun Lee, General Partner

                                                /s/ Jeong Hyun Lee
                                                ---------------------------

                                       8<PAGE>

                                                                    EXHIBIT 10.9

                          SECURITIES PURCHASE AGREEMENT

      SECURITIES PURCHASE AGREEMENT ("Agreement") dated as of July 11, 2005,
between Hansen Gray & Company, Inc., a Nevada corporation (the "Company"), and
iCurie, Inc., a Nevada corporation (the "Purchaser").

                                   WITNESSETH:

      WHEREAS, on December 2, 2004, the Company sold and issued to certain
purchasers (the "Bridge Noteholders") promissory notes in the aggregate
principal amount of Two Million Five Hundred Thousand United States Dollars
($2,500,000 USD) (the "Bridge Promissory Notes");

      WHEREAS, on December 2, 2004, iCurie Lab Holdings, Ltd., a corporation
organized under the laws of the United Kingdom ("iCurie UK"), issued to the
Company a promissory note in the amount of One Million Five Hundred Thousand
United States Dollars ($1,500,000 USD) (the "iCurie UK Note");

      WHEREAS, on July 11, 2005, the Purchaser acquired all of the outstanding
shares in iCurie UK, and the Bridge Noteholders assigned the Bridge Promissory
Notes to the Purchaser in exchange for Series A Preferred Stock issued by the
Purchaser;

      WHEREAS, this Agreement provides that the Company shall cancel the iCurie
UK Note; and the Purchaser shall reduce the Company's indebtedness under the
Bridge Promissory Notes to One Million United States Dollars ($1,000,000 USD) on
the terms and conditions set forth herein;

      WHEREAS, the Purchaser has agreed to loan the Company an additional Five
Hundred Thousand United States Dollars ($500,000 USD), making the Company's
aggregate indebtedness to the Company One Million Five Hundred Thousand United
States Dollars ($1,500,000 USD) which shall be evidenced by a debenture executed
by the Company in favor of the Purchaser (the "Debenture"), which Debenture will
be secured by the Company's proceeds from the Revenue Share Agreement, dated May
18, 2005, between the Company and iCurie UK (the "Revenue Sharing Agreement");

      NOW, THEREFORE, in consideration of the foregoing premises and the
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

                                   ARTICLE I

                       CANCELLATION AND ISSUANCE OF NOTES

      Section 1.1 Cancellation of iCurie UK Note. The Company hereby
acknowledges that the iCurie UK Note is cancelled and any indebtedness owed by
iCurie UK under the iCurie UK Note is hereby null and void.

<PAGE>

      Section 1.2 Cancellation of Bridge Notes. The Purchaser hereby
acknowledges that the Bridge Notes are cancelled and any indebtedness, security
interest or warrants owed by the Company under the Bridge Notes are hereby null
and void.

      Section 1.3 Issuance of the Note. Upon the following terms and conditions,
the Company shall issue the Debenture to the Purchaser. The indebtedness due
under the Debenture shall be One Million Five Hundred Thousand Dollars
($1,500,000 USD) (the "Indebtedness"), which will be secured by the Company's
proceeds from the Revenue Share Agreement.

                                   ARTICLE II

                         REPRESENTATIONS AND WARRANTIES

      Section 2.1 Representations and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser as of
the date hereof:

            (a) Organization and Qualification; Material Adverse Effect. The
Company is a corporation duly incorporated and existing in good standing under
the laws of the State of Nevada and has the requisite corporate power to own its
properties and to carry on its business as now being conducted. The company has
one (1) subsidiary, CyberQuest Partners, Inc., a Florida corporation
("Subsidiaries"). Except where specifically indicated to the contrary, all
references in this Agreement to subsidiaries shall be deemed to refer to all
direct subsidiaries of the Company. The Company is duly qualified as a foreign
corporation to do business and is in good standing in every jurisdiction in
which the nature of the business conducted or property owned by it makes such
qualification necessary other than those in which the failure so to qualify
would not have a Material Adverse Effect. "Material Adverse Effect" means (i)
any adverse effect on the business, operations, properties, prospects or
financial condition of the Company and its subsidiaries, if any, and which is
(either alone or together with all other adverse effects) material to the
Company and its Subsidiaries, if any, taken as a whole, and (ii) any material
adverse effect on the transactions contemplated under the Transaction Documents
or the enforceability thereof.

            (b) Authorization; Enforcement. (i) The Company has all requisite
corporate power and authority to enter into and perform this Agreement, the
Debenture, and the Security Agreement (collectively, the "Transaction
Documents") and to issue the Debenture in accordance with the terms hereof, (ii)
the execution and delivery of the Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby and thereby,
including the issuance of the Debenture, have been duly authorized by all
necessary corporate action, and no further consent or authorization of the
Company, or the Company's Board of Directors (or any committee or subcommittee
thereof) or stockholders is required, (iii) the Transaction Documents have been
duly executed and delivered by the Company, and (iv) the applicable Transaction
Documents constitute valid and binding obligations of the Company enforceable
against the Company, except (A) as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally the enforcement of creditors'
rights and remedies or by other equitable

                                       2
<PAGE>

principles of general application, and (B) to the extent the indemnification
provisions contained in this Agreement may be limited by applicable federal or
state securities laws.

            (c) No Conflicts. The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated hereby and thereby and issuance of the Debenture will
not (i) result in a violation of the Articles of Incorporation, any certificate
of designations, preferences and rights of any outstanding series of preferred
stock of the Company or the By-laws of the Company; (ii) conflict with, or
constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its Subsidiaries is a party, or (iii)
to the Company's knowledge result in a violation of any law, rule, regulation,
order, judgment or decree by which any property or asset of the Company or any
of its Subsidiaries is bound or affected, except in the case of clause (ii),
such conflicts that would not have a Material Adverse Effect.

      Section 2.2 Representations and Warranties of the Purchaser. The Purchaser
hereby makes the following representations and warranties to the Company as of
the date hereof:

            (a) Accredited Investor Status; Sophisticated Purchaser. The
Purchaser is an "accredited investor" as that term is defined in Rule 501(a) of
Regulation D under the 1933 Act. The Purchaser has such knowledge and experience
in financial and business matters that it is capable of evaluating the merits
and risks of the purchase of the Debenture. The Purchaser is not registered as a
broker or dealer under Section 15(a) of the 1934 Act, affiliated with any broker
or dealer registered under Section 15(a) of the 1934 Act, or a member of the
National Association of Securities Dealers, Inc.

            (b) Information. The Purchaser and its advisors, if any, have been
furnished with all materials relating to the business, finances and operations
of the Company which have been requested and materials relating to the offer and
sale of the Debenture which have been requested by the Purchaser or its
advisors. The Purchaser and its advisors, if any, have been afforded the
opportunity to ask questions of the Company. The Purchaser understands that its
purchase of the Debenture involves a high degree of risk. The Purchaser has
sought such accounting, legal and tax advice as it has considered necessary to
make an informed investment decision with respect to its acquisition of the
Debenture.

            (c) No Governmental Review. The Purchaser understands that no United
States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Debenture or the
fairness or suitability of the investment in the Debenture nor have such
authorities passed upon or endorsed the merits thereof.

            (d) Authorization; Enforcement. This Agreement has been duly and
validly authorized, executed and delivered on behalf of the Purchaser and is a
valid and binding agreement of the Purchaser enforceable against the Purchaser
in accordance with its terms, subject as to enforceability to general principles
of equity and to applicable bankruptcy,

                                       3
<PAGE>

insolvency, reorganization, moratorium, liquidation and other similar laws
relating to, or affecting generally, the enforcement of applicable creditors'
rights and remedies. The Purchaser has the requisite corporate power and
authority to enter into and perform its obligations under this Agreement and
each other agreement entered into by the parties hereto in connection with the
transactions contemplated by this Agreement.

            (e) No Conflicts. The execution, delivery and performance of the
Transaction Documents by the Purchaser and the consummation by the Purchaser of
the transactions contemplated hereby and thereby will not (i) result in a
violation of the Articles of Incorporation, any certificate of designations,
preferences and rights of any outstanding series of preferred stock of the
Purchaser or the By-laws of the Purchaser; (ii) conflict with, or constitute a
default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which
the Purchaser is a party, or (iii) to the Purchaser's knowledge result in a
violation of any law, rule, regulation, order, judgment or decree by which any
property or asset of the Purchaser is bound or affected, except in the case of
clause (ii), such conflicts that would not have a material adverse effect on the
Purchaser.

            (f) Investment Representation. The Purchaser is purchasing the
Debenture for its own account and not with a view to distribution in violation
of any securities laws. The Purchaser has been advised and understands that the
Debenture has not been registered under the 1933 Act or under the "blue sky"
laws of any jurisdiction and may be resold only if registered pursuant to the
provisions of the 1933 Act or if an exemption from registration is available,
except under circumstances where neither such registration nor such an exemption
is required by law. The Purchaser has been advised and understands that the
Company, in issuing the Debenture, is relying upon, among other things, the
representations and warranties of the Purchaser contained in this Section 2.2 in
concluding that such issuance is a "private offering" and is exempt from the
registration provisions of the 1933 Act.

            (g) Rule 144. The Purchaser understands that there is no public
trading market for the Debenture, that none is expected to develop, and that the
Debenture must be held indefinitely unless and until such Debenture is
registered under the 1933 Act or an exemption from registration is available.
The Purchaser has been advised or is aware of the provisions of Rule 144
promulgated under the 1933 Act.

            (h) Reliance by the Company. The Purchaser understands that the
Debenture is being offered and sold in reliance on a transactional exemption
from the registration requirements of Federal and state securities laws and that
the Company is relying upon the truth and accuracy of the representations,
warranties, agreements, acknowledgments and understandings of the Purchaser set
forth herein in order to determine the applicability of such exemptions and the
suitability of the Purchaser to acquire the Debenture.

                                       4
<PAGE>

                                  ARTICLE III

                              DELIVERIES AT CLOSING

      Section 3.1 Conditions Precedent to the Obligation of the Company to Sell.
The obligation hereunder of the Company to issue the Debenture and the other
Transaction Documents to the Purchaser is subject to the satisfaction, on the
date hereof, of each of the applicable conditions set forth below. These
conditions are for the Company's sole benefit and may be waived by the Company
by the execution of this Agreement.

            (a) Delivery of Bridge Notes. The Purchaser shall deliver all of the
original Bridge Notes to the Company.

            (b) Termination of Security Agreement. The Security Agreement
between the Bridge Noteholders and the Company shall be terminated.

            (c) Wire. The Purchaser shall have wired $500,000 to the Company's
bank account in accordance with the wire instructions provided by the Company.

      Section 3.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase. The obligation hereunder of the Purchaser to acquire and pay for the
Debenture is subject to the satisfaction, on the date hereof, of each of the
applicable conditions set forth below. These conditions are for the Purchaser's
benefit and may be waived by the Purchaser by the execution of this Agreement.

            (a) Delivery of iCurie UK Note. The Company shall have delivered the
original iCurie UK Note to the Purchaser.

            (b) Security Agreement. A security interest in the Company's
proceeds of the Revenue Sharing Agreement shall have been perfected, pursuant to
a security agreement.

            (c) Definitive Documents. The execution of definitive documentation
including this Agreement, and the Debenture.

                                   ARTICLE IV

                          GOVERNING LAW; MISCELLANEOUS

      Section 4.1 Governing Law. ALL ISSUES AND QUESTIONS CONCERNING THE
CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL
BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF
NEVADA, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICT OF LAW RULES OR
PROVISIONS (WHETHER OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT
WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE
OF NEVADA. EACH PARTY HERETO IRREVOCABLY WAIVES ANY RIGHT TO TRIAL BY JURY.

                                       5
<PAGE>

      Section 4.2 Counterparts. This Agreement may be executed in two or more
identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party; provided that a facsimile signature
shall be considered due execution and shall be binding upon the signatory
thereto with the same force and effect as if the signature were an original, not
a facsimile signature.

      Section 4.3 Headings. The headings of this Agreement are for convenience
of reference and shall not form part of, or affect the interpretation of, this
Agreement.

      Section 4.4 Severability. If any provision of this Agreement shall be
invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement in that jurisdiction or the validity or
enforceability of any provision of this Agreement in any other jurisdiction.

      Section 4.5 Entire Agreement; Amendments; Waivers. This Agreement
supersedes all other prior oral or written agreements between the Purchaser, the
Company, their affiliates and persons acting on their behalf with respect to the
matters discussed herein, and this Agreement and the instruments referenced
herein (including the other Transaction Documents) contain the entire
understanding of the parties with respect to the matters covered herein and
therein and, except as specifically set forth herein or therein, neither the
Company nor the Purchaser makes any representation, warranty, covenant or
undertaking with respect to such matters. No provision of this Agreement may be
amended other than by an instrument in writing signed by the Company and the
Purchaser, and no provision hereof may be waived other than by an instrument in
writing signed by the party against whom enforcement is sought.

      Section 4.6 Notices. Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this
Agreement must be in writing, must be delivered by (i) courier, mail or hand
delivery or (ii) facsimile, and will be deemed to have been delivered upon
receipt to the following addresses:

      If to the Company:

      Hansen Gray & Company, Inc.
      3875 Johns Creek Parkway, Suite A
      Suwanee, Georgia 30024
      Facsimile:  (678) 542-2100

      If to the Secured Party:             with a copy to:

      iCurie, Inc.                         DLA Piper Rudnick Gray Cary US LLP
      c/o iCurie Lab Holdings, Ltd.        203 North LaSalle Street, Suite 1900
      12 Plumtree Court                    Chicago, Illinois 60601
      London                               Attention: Gregory W. Hayes, Esq.
      United Kingdom EC4 A4HT              Facsimile: (312) 630-5310
      Attention: Hakan Wretsell

                                       6
<PAGE>

      Section 4.7 Successors and Assigns. This Agreement may not be assigned
without the prior written consent of the parties. Except as otherwise provided
herein, this Agreement shall be binding upon and inure to the benefit of the
parties and their respective successors and assigns.

      Section 4.8 No Third Party Beneficiaries. This Agreement is intended for
the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.

      Section 4.9 Survival. The representations, warranties and agreements of
the Company and the Purchaser contained in the Agreement shall survive the
Closing.

      Section 4.10 Further Assurances. Each party shall do and perform, or cause
to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents,
as the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.

      Section 4.11 No Strict Construction. The language used in this Agreement
will be deemed to be the language chosen by the parties to express their mutual
intent, and no rules of strict construction will be applied against any party.

                            [SIGNATURE PAGE FOLLOWS]

                                       7
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have caused this Securities
Purchase Agreement to be duly executed as of the date and year first above
written.

COMPANY:                                        PURCHASER:

HANSEN GRAY & COMPANY, INC.                     ICURIE, INC.

By: /s/ David Walker                            By: /s/ Hakan Wretsell
    --------------------------------                ----------------------------
            David M. Walker                                Hakan Wretsell
            ------------------------                       ---------------------
    Its: President                                  Its: Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}]]